Gus A. Baker

23.8k citations

233 papers · 15.4k indexed · 5 hit papers · h-index 69

Impact in

Psychiatry and Mental health top 0.02%
- Epilepsy research and treatment
- Psychosomatic Disorders and Their Treatments
Pediatrics, Perinatology and Child Health top 0.01%
- Pharmacological Effects and Toxicity Studies

Papers in

Psychiatry and Mental health 192
- Epilepsy research and treatment 178
- Psychosomatic Disorders and Their Treatments 20
Pediatrics, Perinatology and Child Health 153
- Pharmacological Effects and Toxicity Studies 145

Co-authors: Ann Jacoby David Chadwick Jill Clayton‐Smith Rebecca Bromley Kimford J. Meador Michael Dewey Dee Snape Albert P. Aldenkamp
Journals: Epilepsy & Behavior (55 papers)Epilepsia (38 papers)Epilepsy Research (18 papers)Seizure (16 papers)Neurology (14 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Gus A. Baker

229 papers receiving 14.8k citations

Hit Papers

5 papers align trajectories log scale

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study 2013 · 513 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 The Lancet Neurology
2013 Epilepsia
2009 New England Journal of Medicine
1997 Epilepsia
1996 Epilepsia

Peers

Countries citing papers authored by Gus A. Baker

Since Specialization

Citations

This map shows the geographic impact of Gus A. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gus A. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gus A. Baker more than expected).

Fields of papers citing papers by Gus A. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gus A. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gus A. Baker. The network helps show where Gus A. Baker may publish in the future.

Co-authors

The 25 scholars most cited alongside Gus A. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gus A. Baker Line = papers co-authored together Gus A. Baker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prospective neuroimaging and neuropsychological evaluation in adults with newly diagnosed focal epilepsy Epilepsia ·Christophe de Bézenac, 福村麻希子, 光亮久慈, Ahmad Ali, Rajiv Mohanraj, Shubhabrata Biswas, Gleidevany Almeida dos Santos, Kieran C. Murphy, Xuecong Ji, Gus A. Baker, Perry Moore, Anthony G Marson, Simon S. Keller	2025	0
2	Diagnostic Challenges in the Neuropsychology of Epilepsy: Report of the ILAE Neuropsychology Task Force Diagnostic Methods Commission: 2021–2025 Epileptic Disorders ·Mary Lou Smith, Luz Nohely Cárdenas Sedano, Genevieve Rayner, Seth A. Margolis, Bruce P. Hermann, Gus A. Baker, Sallie Baxendale, Robyn M. Busch, K. M. D. DEXTRE, Victoria Ives‐Deliperi, Carrie R. McDonald, Urvashi Shah, Sarah J. Wilson	2025	0
3	Core Competencies in Clinical Neuropsychology as a Training Model in Europe Frontiers in Psychology ·Mary H. Kosmidis, Markos Georgiadis, Laura Hokkanen, Fernando Barbosa, 玉泉宋, Gus A. Baker, Erich Kasten, C.D. Mackenzie, Sara Mondini, W Zyrnicki, Tomáš Nikolai, Marıá K. Jónsdóttir, Aistė Pranckevičienė, Erik Hessen, Marios Constantinou	2022	3
4	European Clinical Neuropsychology: Role in Healthcare and Access to Neuropsychological Services Healthcare ·Erich Kasten, Fernando Barbosa, Mary H. Kosmidis, 玉泉宋, Marios Constantinou, Gus A. Baker, Markos Georgiadis, Laura Hokkanen, C.D. Mackenzie, Sara Mondini, Marıá K. Jónsdóttir, W Zyrnicki, Tomáš Nikolai, Aistė Pranckevičienė, R. A. Katz, Erik Hessen	2021	9
5	Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs Health Technology Assessment ·Anthony G Marson, Girvan Burnside, Richard Appleton, Dave Smith, John Paul Leach, Graeme J. Sills, Catrin Tudur Smith, Catrin Plumpton, Dyfrig Hughes, Paula Williamson, Gus A. Baker, Silviya Balabanova, Claire Taylor, Richard Brown, D Hindley, Stephen Howell, Melissa Maguire, Rajiv Mohanraj, Phil E M Smith	2021	10
6	Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial Health Technology Assessment ·Leone Ridsdale, Alison McKinlay, Gabriella Wojewodka, Emily Robinson, Iris Mosweu, Weaver Mm, Adam Noble, Myfanwy Morgan, Stephanie Taylor, Paul McCrone, Sabine Landau, Mark P. Richardson, Gus A. Baker, Laura H. Goldstein	2018	29
7	The effectiveness of a group self‐management education course for adults with poorly controlled epilepsy, SMILE (UK): A randomized controlled trial Epilepsia ·Leone Ridsdale, Gabriella Wojewodka, Emily Robinson, Adam Noble, Myfanwy Morgan, Stephanie Taylor, Paul McCrone, Mark P. Richardson, Gus A. Baker, Sabine Landau, Laura H. Goldstein	2018	21
8	IQ at 6 years after in utero exposure to antiepileptic drugs Neurology ·Gus A. Baker, Rebecca Bromley, Charlton Coles, Christopher P. Cheyne, Morris J. Cohen, Marta García‐Fiñana, Alison Gummery, Rachel Kneen, David W. Loring, George Mawer, Kimford J. Meador, Rebekah Shallcross, Jill Clayton‐Smith, C. Barrie, John R. Beech, Alison Booth, Pete Dixon, Alan Fryer, Shirahama Hiroaki	2014	166
9	Exploring loss and replacement of loss for understanding the impacts of epilepsy onset: A qualitative investigation Epilepsy & Behavior ·Ann Jacoby, Adele Ring, Margaret Whitehead, Anthony G Marson, Gus A. Baker	2014	25
10	Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register BMJ Open ·Udo Wieshmann, Gus A. Baker	2013	26
11	Levels of epilepsy stigma in an incident population and associated factors Epilepsy & Behavior ·Joanne Taylor, Gus A. Baker, Ann Jacoby	2011	103
12	Assessment of effort in clinical testing of cognitive functioning for adults ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) ·T. M. McMillan, Stuart Anderson, Gus A. Baker, Miles Berger, Graham E. Powell, Rachael‐Anne Knight	2009	34
13	Cognitive Function at Three Years of Age After Fetal Exposure to Antiepileptic Drugs Obstetrical & Gynecological Survey ·Kimford J. Meador, Gus A. Baker, N. Andrew Browning, Jill Clayton‐Smith, Deborah T. Combs‐Cantrell, Morris J. Cohen, Laura A. Kalayjian, Andrés M. Kanner, Joyce Liporace, Page B. Pennell, Michael Privitera, David W. Loring	2009	0
14	BEHAVIORAL ABILITIES OF CHILDREN EXPOSED TO CARBAMAZEPINE OR SODIUM VALPROATE IN UTERO: PRELIMINARY PROSPECTIVE EVIDENCE FROM THE LIVERPOOL AND MANCHESTER NEURO-DEVELOPMENT GROUP Epilepsia ·Rebecca Bromley, Rebekah Shallcross, Alison Gummery, G. E. Mawer, Jill Clayton‐Smith, Gus A. Baker	2009	1
15	Nondrug treatments for psychogenic nonepileptic seizures: What’s the evidence? Epilepsy & Behavior ·Jayne Brooks, Laura Goodfellow, Nynke M.G. Bodde, Albert P. Aldenkamp, Gus A. Baker	2007	26
16	Employers' Attitudes to Employment of People with Epilepsy: Still the Same Old Story? Epilepsia ·Ann Jacoby, Greg Curnoe, Gus A. Baker	2005	90
17	Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy Epilepsy & Behavior ·Julie Doughty, Gus A. Baker, Ann Jacoby, Irina Marvel Nathania	2003	58
18	The neuropsychological and emotional consequences of living with intractable temporal lobe epilepsy: implications for clinical management Seizure ·C. Mora, Gus A. Baker	2002	44
19	Learning disability and epilepsy. 2, A review of available outcome measures and position statement on development priorities Seizure ·Colin A. Espie, Mike Kerr, Audrey Z. Paul, Greg O’Brien, Tim Betts, Julia Clark, Ann Jacoby, Gus A. Baker	1997	27
20	Quality of life assessment in diabetes: A preliminary study of young adults in Liverpool Practical Diabetes International ·M Wallymahmed, Gus A. Baker, I. A. MacFarlane	1992	5

About Gus A. Baker

Gus A. Baker is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Cognitive Neuroscience, Cellular and Molecular Neuroscience and Research and Theory, having authored 233 papers that have together received 15.4k indexed citations. Recurring topics across this work include Epilepsy research and treatment (178 papers), Pharmacological Effects and Toxicity Studies (145 papers), Pregnancy and Medication Impact (29 papers), Neuroscience and Neuropharmacology Research (23 papers), Psychosomatic Disorders and Their Treatments (20 papers), Neurobiology of Language and Bilingualism (12 papers), Genetics and Neurodevelopmental Disorders (12 papers) and Functional Brain Connectivity Studies (11 papers). The work is most often cited by research in Psychiatry and Mental health (12.2k citations), Pediatrics, Perinatology and Child Health (9.7k citations), Cellular and Molecular Neuroscience (1.7k citations), Cognitive Neuroscience (1.8k citations) and Public Health, Environmental and Occupational Health (2.2k citations). Gus A. Baker has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Ann Jacoby, David Chadwick, Jill Clayton‐Smith, Rebecca Bromley, Kimford J. Meador, Michael Dewey, Dee Snape, Albert P. Aldenkamp, Deborah Buck and David W. Loring. Their work appears in journals such as Epilepsy & Behavior, Epilepsia, Epilepsy Research, Seizure and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact